1. Home
  2. BLCO vs NNI Comparison

BLCO vs NNI Comparison

Compare BLCO & NNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • NNI
  • Stock Information
  • Founded
  • BLCO 1853
  • NNI 1978
  • Country
  • BLCO Canada
  • NNI United States
  • Employees
  • BLCO N/A
  • NNI N/A
  • Industry
  • BLCO Ophthalmic Goods
  • NNI Finance: Consumer Services
  • Sector
  • BLCO Health Care
  • NNI Finance
  • Exchange
  • BLCO Nasdaq
  • NNI Nasdaq
  • Market Cap
  • BLCO 5.2B
  • NNI 4.8B
  • IPO Year
  • BLCO 2022
  • NNI 2003
  • Fundamental
  • Price
  • BLCO $14.97
  • NNI $129.76
  • Analyst Decision
  • BLCO Hold
  • NNI
  • Analyst Count
  • BLCO 12
  • NNI 0
  • Target Price
  • BLCO $15.91
  • NNI N/A
  • AVG Volume (30 Days)
  • BLCO 490.9K
  • NNI 66.9K
  • Earning Date
  • BLCO 10-29-2025
  • NNI 11-06-2025
  • Dividend Yield
  • BLCO N/A
  • NNI 0.92%
  • EPS Growth
  • BLCO N/A
  • NNI 116.62
  • EPS
  • BLCO N/A
  • NNI 9.04
  • Revenue
  • BLCO $4,891,000,000.00
  • NNI $1,559,342,000.00
  • Revenue This Year
  • BLCO $8.29
  • NNI $12.03
  • Revenue Next Year
  • BLCO $5.82
  • NNI $4.87
  • P/E Ratio
  • BLCO N/A
  • NNI $14.39
  • Revenue Growth
  • BLCO 8.81
  • NNI 21.39
  • 52 Week Low
  • BLCO $10.45
  • NNI $98.15
  • 52 Week High
  • BLCO $21.08
  • NNI $136.17
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 53.23
  • NNI 55.55
  • Support Level
  • BLCO $14.67
  • NNI $127.78
  • Resistance Level
  • BLCO $15.31
  • NNI $131.09
  • Average True Range (ATR)
  • BLCO 0.45
  • NNI 2.85
  • MACD
  • BLCO -0.00
  • NNI 0.07
  • Stochastic Oscillator
  • BLCO 78.25
  • NNI 61.09

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About NNI Nelnet Inc.

Nelnet Inc is a United States based company engaged in these four reportable segments; Loan Servicing and Systems focuses on student and consumer loan origination services and servicing, loan origination and servicing-related technology solutions, and outsourcing business services; Education Technology Services and Payments segment provides education services, payment technology, and community management solutions for K-12 schools, institutions, churches, and businesses; Asset Generation and Management segment includes the acquisition and management of student and other loan assets; and Nelnet Bank focuses on the private education and unsecured consumer loan markets. Maximum revenue for the company is generated from its Education Technology Services and Payments segment.

Share on Social Networks: